In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Snack rats eat biobased fiber optic cables, send London’s G.Network into bankruptcy
In the United Kingdom, London internet provider G.Network has entered administration because it used fiber optic cable jackets made of soy- and corn-based materials...
Samsung creates e-paper with phytoplankton display
In South Korea, Samsung Electronics has unveiled an e-paper with a display made of phytoplankton-based plastics.
E‑paper is a display technology that replicates the...
Make Good launches mushroom-based shoes
In Australia, shoe brand Make Good has created a Derby shoe style with a variety of biobased materials. Dubbed Derby V1, the shoe includes...